Implementation of long-acting cabotegravir and rilpivirine in vulnerable populations with complex needs: primary 48-week results of JABS

Mina John is a consultant Clinical Immunologist and Immunopathologist at Royal Perth Hospital, Western Australia, which provides a large ambulatory, inpatient and community outreach HIV care service. She is also maintains research interests in HIV cellular immunology and virology with academic appointments with the Insitute of Immunolgy and Infectious diseases, Murdoch University and the School of Human Sciences, University of Western Australia.